跳至主要内容
临床试验/DRKS00004265
DRKS00004265尚未招募未知

Randomized controlled trial on the efficacy of bloodletting for arterial hypertension

Immanuel Krankenhaus Berlin WannseeHochschulambulanz für Naturheilkunde der Charité Universitätsmedizin Abteilung für Naturheilkunde0 个研究点目标入组 60 人开始时间: 2012年7月23日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Open (masking not used)

入排标准

年龄范围
30 Years 至 70 Years(—)
性别
All

入选标准

  • between 30 and 70 years of age;
  • - manifest arterial hypertension, NICE/WHO stadium I (= 140-159 mmHg syst. and 90-99mmHg diast.) that hasn't been treated pharmacologically yet;
  • - Patients in Stadium II (= 160-179 mmHg syst. and 100-109 mmHg diast.) can only be included if they reject pharmacologic therapy because of intolerances to drugs (twofoldly documented in specialist-consultation by cardiologist or nephrologist).

排除标准

  • - demonstrably elevated cardiovascular risk with prevalence of at least one of the following 4 risk factors: 1) known coronary heart disease 2) renal insufficiency with microalbuminuria (precluded by laboratory-analysis) 3) known diabetes mellitus 4) known retinopathy;
  • - elevated cerebrovascular risk with 1) known stenosis of common carotid artery, or anamnesis with 2) transient ischemic attack or 3) cerebral infarction
  • - consisting coagulation disorder, known hemophilia or pharmacological anticoagulants;
  • - pregnancy
  • - patients with acute infections
  • - patients with consisting anemia

研究者

发起方
Immanuel Krankenhaus Berlin WannseeHochschulambulanz für Naturheilkunde der Charité Universitätsmedizin Abteilung für Naturheilkunde

相似试验